Biallelic variants in FBXL3 cause intellectual disability, delayed motor development and short stature.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
15 03 2019
Historique:
received: 18 09 2018
revised: 13 11 2018
accepted: 14 11 2018
pubmed: 28 11 2018
medline: 10 3 2020
entrez: 28 11 2018
Statut: ppublish

Résumé

FBXL3 (F-Box and Leucine Rich Repeat Protein 3) encodes a protein that contains an F-box and several tandem leucine-rich repeats (LRR) domains. FBXL3 is part of the SCF (Skp1-Cullin-F box protein) ubiquitin ligase complex that binds and leads to phosphorylation-dependent degradation of the central clock protein cryptochromes (CRY1 and CRY2) by the proteasome and its absence causes circadian phenotypes in mice and behavioral problems. No FBXL3-related phenotypes have been described in humans. By a combination of exome sequencing and homozygosity mapping, we analyzed two consanguineous families with intellectual disability and identified homozygous loss-of-function (LoF) variants in FBXL3. In the first family, from Pakistan, an FBXL3 frameshift variant [NM_012158.2:c.885delT:p.(Leu295Phefs*25)] was the onlysegregating variant in five affected individuals in two family loops (LOD score: 3.12). In the second family, from Lebanon, we identified a nonsense variant [NM_012158.2:c.445C>T:p.(Arg149*)]. In a third patient from Italy, a likely deleterious non-synonymous variant [NM_012158.2:c.1072T>C:p.(Cys358Arg)] was identified in homozygosity. Protein 3D modeling predicted that the Cys358Arg change influences the binding with CRY2 by destabilizing the structure of the FBXL3, suggesting that this variant is also likely to be LoF. The eight affected individuals from the three families presented with a similar phenotype that included intellectual disability, developmental delay, short stature and mild facial dysmorphism, mainly large nose with a bulbous tip. The phenotypic similarity and the segregation analysis suggest that FBXL3 biallelic, LoF variants link this gene with syndromic autosomal recessive developmental delay/intellectual disability.

Identifiants

pubmed: 30481285
pii: 5210221
doi: 10.1093/hmg/ddy406
pmc: PMC6400105
doi:

Substances chimiques

F-Box Proteins 0
FBXL3 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

972-979

Subventions

Organisme : NIGMS NIH HHS
ID : P41 GM103311
Pays : United States

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Références

Hum Mutat. 2014 Oct;35(10):1203-10
pubmed: 25044680
BMC Bioinformatics. 2015 Sep 28;16:310
pubmed: 26415661
Cell. 2007 Jun 1;129(5):1011-23
pubmed: 17462724
Hum Genet. 2017 Nov;136(11-12):1419-1429
pubmed: 28940097
Neurol Sci. 2002 Mar;22(6):443-7
pubmed: 11976975
Clin Genet. 2010 Nov;78(5):478-83
pubmed: 20345473
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Mol Psychiatry. 2017 Apr;22(4):615-624
pubmed: 27431290
Neurol Sci. 2005 Jun;26(2):108-16
pubmed: 15995827
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
PLoS One. 2012;7(6):e38263
pubmed: 22719873
Proc Natl Acad Sci U S A. 2010 Jan 26;107 Suppl 1:1779-86
pubmed: 19805052
Clin Genet. 2014 Feb;85(2):101-10
pubmed: 23895455
Am J Med Genet A. 2010 Feb;152A(2):319-26
pubmed: 20082458
Mol Psychiatry. 2017 Nov;22(11):1604-1614
pubmed: 27457812
Nature. 2012 Nov 1;491(7422):56-65
pubmed: 23128226
Cell Rep. 2015 Jan 13;10(2):148-61
pubmed: 25558065
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Nucleic Acids Res. 2007 Jan;35(Database issue):D61-5
pubmed: 17130148
Am J Med Genet A. 2014 Feb;164A(2):441-8
pubmed: 24357076
Am J Hum Genet. 2015 Mar 5;96(3):386-96
pubmed: 25704603
Eur J Hum Genet. 2012 May;20(5):490-7
pubmed: 22258526
Cold Spring Harb Symp Quant Biol. 2007;72:251-259
pubmed: 18419282
Genet Med. 2018 Jul;20(7):778-784
pubmed: 28837161
Hum Mol Genet. 2018 Aug 1;27(15):2703-2711
pubmed: 29771303
Cell. 2016 Aug 25;166(5):1198-1214.e24
pubmed: 27565346
J Mol Biol. 2002 Jul 5;320(2):369-87
pubmed: 12079393
Eur J Hum Genet. 2011 Nov;19(11):1161-6
pubmed: 21629298
Res Dev Disabil. 2011 Mar-Apr;32(2):419-36
pubmed: 21236634
Nat Rev Genet. 2016 Jan;17(1):9-18
pubmed: 26503795
Science. 2007 May 11;316(5826):897-900
pubmed: 17463252
Trends Genet. 2014 Jan;30(1):32-9
pubmed: 24176302
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
Am J Hum Genet. 2018 Oct 4;103(4):568-578
pubmed: 30290152
Acta Neurol Scand. 1993 Jul;88(1):70-4
pubmed: 8372633
Cell. 2013 Feb 28;152(5):1091-105
pubmed: 23452855
Res Dev Disabil. 2013 Apr;34(4):1144-51
pubmed: 23376049
Hum Hered. 2014;77(1-4):150-60
pubmed: 25060278
Nature. 2013 Apr 4;496(7443):64-8
pubmed: 23503662
Am J Med Genet. 2001 Aug 1;102(2):153-6
pubmed: 11477608
J Neurodev Disord. 2010 Dec;2(4):182-209
pubmed: 21124998
Ment Retard Dev Disabil Res Rev. 2002;8(3):117-34
pubmed: 12216056
Clin Genet. 2013 Sep;84(3):203-8
pubmed: 23451714
Int J Biol Sci. 2017 May 16;13(5):669-681
pubmed: 28539839
Sci Rep. 2017 Dec 19;7(1):17765
pubmed: 29259298
J Intellect Disabil Res. 2006 Oct;50(Pt 10):701-10
pubmed: 16961699
Funct Neurol. 1987 Apr-Jun;2(2):189-94
pubmed: 3666548
Am J Hum Genet. 2016 Apr 7;98(4):615-26
pubmed: 26996948
Science. 2007 May 11;316(5826):900-4
pubmed: 17463251
Hum Genet. 2014 Aug;133(8):975-84
pubmed: 24623383
Cell. 2013 Feb 28;152(5):1106-18
pubmed: 23452856
N Engl J Med. 2013 Oct 17;369(16):1502-11
pubmed: 24088041
Nature. 2011 Sep 21;478(7367):57-63
pubmed: 21937992
Am J Hum Genet. 2006 May;78(5):889-896
pubmed: 16642444
Genes Dev. 2004 Nov 1;18(21):2573-80
pubmed: 15520277

Auteurs

Muhammad Ansar (M)

Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland.

Sohail Aziz Paracha (SA)

Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan.

Alessandro Serretti (A)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Muhammad T Sarwar (MT)

Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan.

Jamshed Khan (J)

Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan.

Emmanuelle Ranza (E)

Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland.
Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.

Emilie Falconnet (E)

Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland.

Justyna Iwaszkiewicz (J)

Swiss Institute of Bioinformatics, Molecular Modeling Group, Batiment Genopode, Unil Sorge, Lausanne, Switzerland.

Sayyed Fahim Shah (SF)

Department of Medicine, KMU Institute of Medical Sciences, Kohat, Pakistan.

Azhar Ali Qaisar (AA)

Radiology Department, Lady Reading Hospital, Peshawar, Pakistan.

Federico A Santoni (FA)

Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland.
Department of Endocrinology Diabetes and Metabolism, University Hospital of Lausanne, Lausanne, Switzerland.

Vincent Zoete (V)

Swiss Institute of Bioinformatics, Molecular Modeling Group, Batiment Genopode, Unil Sorge, Lausanne, Switzerland.
Department of Fundamental Oncology, Lausanne University, Ludwig Institute for Cancer Research, Route de la Corniche 9A, Epalinges, Switzerland.

Andre Megarbane (A)

Institut Jerome Lejeune, Paris, France.

Jawad Ahmed (J)

Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan.

Roberto Colombo (R)

Institute of Clinical Biochemistry, Faculty of Medicine, Catholic University IRCCS Policlinico Gemelli, Rome, Italy.
Center for the Study of Rare Hereditary Diseases, Niguarda Ca' Granda Metropolitan Hospital, Milan, Italy.

Periklis Makrythanasis (P)

Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland.
Biomedical Research Foundation of the Academy of Athens, Athens, Greece.

Stylianos E Antonarakis (SE)

Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland.
Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
iGE3 Institute of Genetics and Genomics of Geneva, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH